Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...

Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases: Cambridge, Massachusetts Saturday, October 1 ...

Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries: Winnipeg, Manitoba Saturday, October 19, 2024, 16:00 H ...

Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities: Nivelles, Belgium Saturday, Oct ...

Gland Pharma’s board has approved the appointment of Shyamakant Giri as the new chief executive officer (CEO) of the company. Giri is to join the company with effect from January 15, 2025. Giri is a ...

TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics: Tampa, Florida Saturday, October 19, 2024, 15:00 Hrs [IST] TuHURA Biosciences, a phase 3 r ...

Nandita Vijayasimha, Bengaluru Saturday, October 19, 2024, 08:00 Hrs [IST] ...

Gujarat FDCA rolls out training for 150 officers on Revised Schedule M Guidelines: Shardul Nautiyal, Mumbai Saturday, October ...

MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease: New York Saturday, October 19, 2024, 11:00 Hrs [IST] The Mic ...

UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths: United Kingdom Saturday, October 19, 2024, 13:00 Hrs [IST] The UK go ...

Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024: Rahway, New Jersey Saturday, October ...

Our Bureau, Mumbai Saturday, October 19, 2024, 12:30 Hrs [IST] ...